Utrogestan
Sponsors
Amsterdam UMC Stichting, nor zila hassan malek, Insel Gruppe AG, University Hospital Bern, National University of Malaysia, Assaf-Harofeh Medical Center
Conditions
(peri) MenopauseClimacteric symptomsDiabetes MellitusGene AbnormalityInsomniaLuteal PhaseMenopauseMiscarriage
Phase 2
Phase 4
Progesterone and Resting Energy Expenditure
TerminatedNCT04140968
Start: 2019-11-01End: 2021-05-27Updated: 2022-03-31
Gonadotropin Releasing Hormone Agonist (GnRHa) Versus Estrogen and Progesterone for Luteal Support in High Responders
NCT04797338
Start: 2017-12-29End: 2021-09-30Target: 100Updated: 2021-04-01
The role of online sleep intervention and hormone therapy on sleep, climacteric symptoms and mood in the perimenopause
RecruitingCTIS2024-512071-12-00
Start: 2025-10-29Target: 222Updated: 2025-10-22
The effect of transdermal 17-β-estradiol/progesterone supplementation on glucose regulation in peri- and postmenopausal women with type 1 and type 2 diabetes
Not yet recruitingCTIS2025-523214-83-00
Target: 48Updated: 2025-12-15